Table 1 Genes downregulated by AI treatment
From: Molecular response to aromatase inhibitor treatment in primary breast cancer
ID | Symbol | Description | Unigene | Fold | LFDR |
|---|---|---|---|---|---|
HSI182A05 | TFF1 | Trefoil factor 1 (breast cancer, estrogen-inducible) | Hs.162807 | 0.26 | 0.09 |
HSI054D07 | HBB | Haemoglobin, beta | Hs.523443 | 0.31 | 0.00 |
HSI047B01 | PDZK1 | PDZ domain containing 1 | Hs.444751 | 0.35 | 0.00 |
HSI035H02 | CYP2B6 | Cytochrome P450, family 2B6 | Hs.1360 | 0.41 | 0.04 |
HSI075H09 | AGR2 | Anterior gradient 2 homolog (Xenopus laevis) | Hs.530009 | 0.41 | 0.08 |
HSI031E07 | STARD10 | START domain containing 10 | Hs.188606 | 0.42 | 0.00 |
HSI183G10 | TFF3 | Trefoil factor 3 (intestinal) | Hs.82961 | 0.43 | 0.00 |
HSI147F09 | ZBTB20 | Zinc finger and BTB domain containing 20 | Hs.570657 | 0.45 | 0.00 |
HSI182A08 | STC2 | Stanniocalcin 2 | Hs.233160 | 0.47 | 0.00 |
HSI147F08 | KTN1 | Kinectin 1 (kinesin receptor) | Hs.509414 | 0.47 | 0.00 |
HSI059H10 | LOC143381 | Hypothetical protein LOC143381 | Hs.388347 | 0.47 | 0.00 |
HSI147F10 | MSI2 | Musashi homolog 2 (Drosophila) | Hs.134470 | 0.49 | 0.00 |
HSI177G07 | EST | Transcribed locus | Hs.443277 | 0.50 | 0.10 |
HSI053H02 | UBE2C | Ubiquitin-conjugating enzyme E2C | Hs.93002 | 0.52 | 0.10 |
HSI096C06 | MAPT | Microtubule-associated protein tau | Hs.101174 | 0.52 | 0.00 |
HSI049A02 | ERGIC1 | ER-golgi intermediate compartment 1 | Hs.509163 | 0.53 | 0.09 |
HSI040C08 | AZGP1 | Alpha-2-glycoprotein 1, zinc | Hs.546239 | 0.55 | 0.00 |
HSI133F06 | EST | Transcribed locus | Hs.159264 | 0.55 | 0.00 |
HSI182E08 | PLAT | Plasminogen activator, tissue | Hs.491582 | 0.55 | 0.00 |
HSI033B05 | LY6E | Lymphocyte antigen 6 complex, locus E | Hs.521903 | 0.56 | 0.00 |
HSI048F12 | CCND1 | Cyclin D1 | Hs.523852 | 0.56 | 0.10 |
HSI085G12 | KCNK15 | Potassium channel, subfamily K, member 15 | Hs.528664 | 0.57 | 0.00 |
HSI177H07 | PCBP3 | Poly(rC) binding protein 3 | Hs.474049 | 0.57 | 0.10 |
HSI032D02 | ABCA3 | ATP-binding cassette, subfamily A3 (ABC1) | Hs.26630 | 0.57 | 0.00 |
HSI182A02 | TFF3 | Trefoil factor 3 (intestinal) | Hs.82961 | 0.58 | 0.04 |
HSI025A03 | FGD3 | FYVE, RhoGEF and PH domain containing 3 | Hs.411081 | 0.58 | 0.00 |
HSI070B06 | AP1S1 | Adaptor-related protein complex 1, sigma 1 subunit | Hs.489365 | 0.58 | 0.08 |
HSI057H12 | GNB2 | Guanine nucleotide binding protein beta 2 | Hs.185172 | 0.58 | 0.00 |
HSI080H11 | SEMA3F | Semaphorin 3F | Hs.32981 | 0.59 | 0.00 |
HSI054G06 | NUSAP1 | Nucleolar and spindle associated protein 1 | Hs.511093 | 0.59 | 0.00 |
HSI124D07 | RIMS4 | Regulating synaptic membrane exocytosis 4 | Hs.517065 | 0.59 | 0.00 |
HSI065C09 | CNNM2 | Cyclin M2 | Hs.500903 | 0.59 | 0.00 |
HSI080F02 | PREX1 | PIP3-dependent RAC exchanger 1 | Hs.153310 | 0.59 | 0.00 |
HSI095H09 | C6orf97 | Chromosome 6 open reading frame 97 | Hs.130239 | 0.59 | 0.00 |
HSI161G02 | EST | Transcribed locus | Hs.570637 | 0.60 | 0.00 |
HSI045G02 | UBE2T | Ubiquitin-conjugating enzyme E2T (putative) | Hs.5199 | 0.60 | 0.00 |
HSI046F10 | TOP2A | Topoisomerase (DNA) II alpha 170 kDa | Hs.156346 | 0.60 | 0.00 |
HSI183D04 | AR | Androgen receptor | Hs.496240 | 0.61 | 0.01 |
HSI183A08 | SLC9A3R1 | Solute carrier family 9, member 3 regulator 1 | Hs.396783 | 0.61 | 0.00 |
HSI025G02 | SHARPIN | SHANK-associated RH domain interactor | Hs.529755 | 0.61 | 0.08 |